Prospective randomised study of double hemi-body irradiation with and without subsequent maintenance recombinant alpha 2b interferon on survival in patients with relapsed multiple myeloma
- 31 December 1992
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (8-9) , 1392-1395
- https://doi.org/10.1016/0959-8049(92)90527-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Chemotherapy is superior to sequential hemibody irradiation for remission consolidation in multiple myeloma: a Southwest Oncology Group study.Journal of Clinical Oncology, 1990
- Modern trends in the treatment of multiple myelomaCurrent Opinion in Oncology, 1990
- Hemibody irradiation. An effective second-line therapy in drug-resistant multiple myelomaCancer, 1989
- Sequential Half-Body Irradiation as Salvage Therapy in Chemotherapy-Resistant Multiple MyelomaAmerican Journal of Clinical Oncology, 1988
- Evidence for peripheral blood B lymphocyte but not T lymphocyte involvement in multiple myelomaBlood, 1987
- Treatment of multiple myeloma with recombinant alpha-interferonBlood, 1986
- Hemibody irradiation in multiple myelomaRadiotherapy and Oncology, 1985
- Systemic irradiation in multiple myeloma: a report on nineteen casesBritish Journal of Haematology, 1984
- Sequential hemi-body radiotherapy in advanced multiple myelomaCancer, 1979
- Total body irradiation for myelomatosis.BMJ, 1971